Brief Report: First-line Pembrolizumab in Metastatic Non-Small Cell Lung Cancer Habouring MET Exon 14 Skipping Mutation and PD-L1 ≥50% (GFPC 01-20 Study).
作者信息
Guisier Florian, Descourt Renaud, Babey Helene, Huchot Eric, Falchero Lionel, Veillon Remi, Cortot Alexis B, Tissot Claire, Chouaid Christos, Decroisette Chantal
机构信息
Department of Pneumology and Inserm CIC-CRB 1404, Normandie Univ, UNIROUEN, LITIS Lab QuantIF team EA4108, CHU Rouen, Rouen, France.
Institut de cancérologie, Hopital Morvan, CHRU Brest, Brest, France.
出版信息
Clin Lung Cancer. 2022 Dec;23(8):e545-e549. doi: 10.1016/j.cllc.2022.09.002. Epub 2022 Sep 17.
PMID:36210290
Abstract
摘要
Zotero 插件